Dale Bryansmith , M.D.
Dale Bryansmith, M.D. is a board-certified medical oncologist with Greater Philadelphia Cancer and Hematology Specialists, P.C. Dr. Bryansmith has contributed to writings in the Journal of Medicinal Chemistry, and is currently preparing an article regarding Serum Ferritin usage in assessment of iron status in patients with co-existent disease.
Dr. Bryansmith became an honorary member of the leading academic society, Phi Beta Kappa, in 1972 and received his medical degree at the University of Cincinnati, School of Medicine. He completed residency training in Medicine at the Medical College of Pennsylvania, and fellowship training in hematology/oncology at Emory University Affiliated Hospitals. Dr. Bryansmith holds certification in medical oncology and hematology.
Allen E. Lord Terzian , M.D.
Allen E. Lord Terzian, M.D. received his medical degree with honors and distinction, from Hahnemann University Hospital, and completed residency and fellowship at his alma mater as well. Dr. Terzian serves as the Principal Investigator for several Frankford Hospital research programs including the Eastern Conference Oncology Group Trials, the Jefferson Oncology Group Trials, and the National Surgical Breast and Bowel Project.
Dr. Terzian’s significant affiliation with Frankford Hospital includes key roles as Chief, Division of Hematology and Oncology; Medical Director of the Frankford Hospital Cancer Center; and President-Elect of the Frankford Hospital Medical Staff.
Dr. Terzian has maintained committee seats with Frankford Hospital since 1993. His roles include Chairman of the Frankford Hospital Tumor Board, and the Executive and Credentials Committees. He also serves on the Frankford Hospital Cancer Care Task Force and Breast Health Task Force.
His works have been published in numerous journals including Proceedings of American Society of Clinical Oncology (ASCO), Basic Pharmacology in Medicine, American Society of Nephrology, and ASAIO Transactions. Dr. Terzian is a member of ASCO and the Delaware County and Pennsylvania Medical Societies.
Julia M. Kennedy , D.O.
Julia M. Kennedy, D.O. received her medical degree from the Philadelphia College of Osteopathic Medicine. She is board certified in Internal Medicine, Medical Oncology and Hematology. She completed her fellowship in Hematology and Oncology at Pennsylvania Hospital, and completed her internal medicine residency through a program at Delaware Valley Medical Center with rotations at Hahnemann University, Deborah Heart and Lung, and Medical College of Pennsylvania. She was Magna Cum Laude graduate of Temple University where she also received academic distinction of the honoree Phi Beta Kappa.
She maintains a special focus in the care of women with breast cancer and is Director of the Breast Evaluation Center, a multidisciplinary team evaluating all new breast cancer patients at the Frankford Hospital Cancer Center. She is on the medical advisory board of Gilda's Club, a support group for cancer patients and their caretakers. She has lectured and has an interest in developing programs with health and wellness in recovery from cancer treatment and survivorship.
She is a member of the adjunct faculty of the Philadelphia College of Osteopathic Medicine and has been an instructor for a number of years to third and fourth year medical students during their clinical rotations.
James J. Perry , M.D.
James J. Perry, M.D. received his medical degree at Hahnemann University and was awarded the Magna Cum Laude distinction at LaSalle University in his undergraduate studies. Dr. Perry completed his Internal Medicine internship and residency at Letterman Army Medical Center in San Francisco, CA, and his Hematology-Oncology fellowship at Walter Reed Army Medical Center in Washington, D.C. He was on the Hematology-Oncology staff at Wa1ter Reed Army Medical Center following his fellowship completion. Dr. Perry completed 10 years of service in the Army Medical Corps in 1991 and was awarded the Army Commendation Medal.
Dr. Perry was an Assistant Professor in the Division of Hematology-Oncology at the Comprehensive Cancer Center, Wake Forest University School of Medicine from 1992-1998 where his focus was in Blood Stem Cell and Bone Marrow Transplantation and the treatment of Leukemia and Lymphoma.
Dr. Perry returned to the Philadelphia area in 1999 to join the practice of Greater Philadelphia Cancer and Hematology Specialists. He is board-certified in Internal Medicine, Medical Oncology and Hematology. Dr. Perry is a member of the Alpha Omega Alpha (AOA) Medical Honor Society, the American College of Physicians (ACP), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the American Society for Blood and Marrow Transplantation (ASBMT).
Dr. Perry has held numerous administrative positions including Member, Institutional Review Board (IRB), Member, Transplantation Task Force, and Associate Director of Bone Marrow Transplantation at Wake Forest University Medical Center. He holds the position of Chairman of the IRB of the Frankford Hospital System and is also a member of the Frankford Hospital Pharmacy Committee.
Frederick G. Dold , M.D.
Frederick G. Dold, M.D. obtained his medical degree from the Hahnemann University School of Medicine where he graduated in the top 20% of his graduating class, and completed his residency and fellowship through Thomas Jefferson University Hospital.
Dr. Dold was a 2002 ASCO Merit Award Winner for his poster presentation: "Hypersensitivity in patients with metastatic colorectal carcinoma undergoing chemotherapy with oxaliplatin."
In addition to this recognition, Dr. Dold has written several presentations including “Phase II trial of ZD1839 (Iressa)/Capecitabine in Patients with Metastatic Colorectal Cancer who have previously received 5-Fluorouracil/Irinotecan and Oxaliplatin therapy” and “Weekly Docetaxel, Cisplatin with Daily Celecoxib and Concurrent Radiotherapy for Patients with Locally Advanced Head and Neck Cancer.” Both of these Protocols have been submitted for review. He has been involved in numerous Poster Presentations including the “Effects of recombinant human erythropoietin (r-HuEPO) injections in patients receiving Cisplatin chemotherapy treatments”- a research project with Dr. David Henry, Philadelphia, PA.
An accomplished lecturer, Dr. Dold has been an invited speaker at the Jefferson Hospital Internal Medicine Residency Program, and the Cardeza Foundation of Hematological Research Grand Rounds, Jefferson Hospital.
Moshe C. Chasky, M.D.
Moshe C. Chasky, M.D. received his medical degree from Tel Aviv University-Sackler School of Medicine. Dr. Chasky completed residency at NYU Downtown Hospital and accomplished fellowship at the Hematology/Medical Oncology Fox Chase Cancer Center as well as Temple University/Fox Chase Cancer Center.
Dr. Chasky has been published in notable journals including Case Studies in Breast Cancer for his review on the “Treatment of a patient with HER-2-positive breast cancer: Options in HER-2-directed therapy.”
In 2004, Dr. Chasky was awarded the Outstanding Resident, Internal Medicine and Assistant Chief Resident Internal Medicine at NYU Downtown Hospital.